4//SEC Filing
LAUDER RONALD S 4
Accession 0001001250-21-000038
CIK 0001001250other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 2:00 PM ET
Size
9.2 KB
Accession
0001001250-21-000038
Insider Transaction Report
Form 4
LAUDER RONALD S
Chairman, Clinique Labs, LLC10% Owner
Transactions
- Sale
Class A Common Stock
2021-03-02$289.97/sh−46,370$13,445,909→ 32,001 total - Sale
Class A Common Stock
2021-03-02$291.09/sh−22,127$6,440,948→ 9,874 total - Sale
Class A Common Stock
2021-03-02$291.82/sh−9,874$2,881,431→ 0 total
Holdings
- 6,364(indirect: By Trust)
Class A Common Stock
Footnotes (5)
- [F1]The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range.
- [F2]Sales prices range from $289.45 to $290.31 per share, inclusive.
- [F3]Sales prices range from $290.49 to $291.48 per share, inclusive.
- [F4]Sales prices range from $291.51 to $292.42 per share, inclusive.
- [F5]RSL disclaims beneficial ownership of these shares to the extent he does not have a pecuniary interest in such securities.
Documents
Issuer
ESTEE LAUDER COMPANIES INC
CIK 0001001250
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0000942617
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 2:00 PM ET
- Size
- 9.2 KB